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1251-labelled angiotensin II (A II) specifically binds to solubilized receptors extracted from rat isolated 
glomeruli using CHAPS (3-[3-(cholamidopropyl)dimethylammonio]-l-propanesulfonate). The yield of 
solubilization of the binding sites was 3.3%. Equilibrium was reached after 15-20 min and specific binding 
represented 75% of total binding. Dissociation of the hormone-receptor complex after addition of an 
excess of A II was very slow in the presence of Ca*+ and Mg*+. [Sar’ Alas] A II and [Sar’ Ileg] A II were 
more potent as competitive inhibitors of 12’I-labelled A II than A II itself and its heptapeptide. These basic 
features of 1251-labelled A II binding to the extracted material were similar to those observed previously 
with untreated glomeruli. 
Angiotensin II Glomerulus Solubilized receptor Detergent Binding study 
Angiotensin II heptapeptide 
1. INTRODUCTION 
Murine and human glomeruli possess specific 
receptors for angiotensin II (A II) which are linked 
to glomerular vasoreactivity [ 1,2]. Solubilization 
and characterization of high-affinity A II recep- 
tors derived from rabbit aorta membranes, bovine 
adrenal cortex or dog adrenal cortex and uterus 
have been performed by extraction with various 
detergents, deoxycholate [3], digitonin [4] or 
Triton X-100 [5]. A major problem in solubilizing 
A II receptors is the rapid loss of binding activity 
when particulate receptors are treated with ionic or 
nonionic detergents [5,6]. This problem has been 
overcome using photoaffinity labelling [5] or 
chemical crosslinking [7] which both provide a 
stable hormone-receptor complex. These tech- 
niques allow the analysis of the receptor species 
itself but prevent us from studying the characteris- 
tics of binding to the soluble material. Here, we 
report the solubilization of the previously studied 
A II-binding sites of rat glomeruli with a more 
recently described Zwitterionic detergent, CHAPS 
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(3 - [3 -cholamidopropyl)dimethylammonio] - 1 -pro- 
panesulfonate) which has been demonstrated as 
both more effective at breaking protein-protein 
interactions and less capable of denaturing activity 
than the other solubilizing agents [8,9]. 
2. MATERIALS AND METHODS 
[Asn’, Va15] A II was donated by Ciba-Geigy 
(Basel) and labelled with “‘1 as in [lo]. Labelled 
and unlabelled molecules were separated with 
polyacrylamide gel electrophoresis as in [l I]. The 
specific activity of the labelled hormone was 
2000 Ci/mmol which corresponds to one atom 
iodine per molecule. [Asp’, Be’] A II, [Des Asp’, 
Ile’] A II, [Sar’, Ala81 A II and [Sar’, Be’] A II 
were purchased from Beckman (Geneva, Switzer- 
land) and ACTH-(1-24) was a gift of Ciba-Geigy. 
CHAPS was obtained from Sigma (St. Louis, 
MO). 
Glomeruli were isolated from the renal cortex of 
male Sprague-Dawley rats weighing 150-200 g as 
in [12]. The final pellet was checked for purity 
under light microscopy. Tubular fragments were 
always below 2% of the total number of glomeruli. 
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Glomeruli were suspended in 20 mM Tris-HCl 
buffer, pH 7.5, containing 135 mM NaCl, 10 mM 
KCL, 10 mM NaCH3COO and 5 mM glucose 
(buffer A). The preparation was kept frozen and 
used within the next 48 h. On the day of the experi- 
ment, glomeruli were resuspended in buffer A plus 
1 mM CaC12 and 1 mM MgCl2. Both cations have 
been demonstrated as enhancing the binding of 
A II to its glomerular receptors [ 131. The suspen- 
sion was sonicated for 2 min (Branson Sonic 
Power, Danbury, CO), adjusted to a protein con- 
centration of 15 mg/ml and incubated at room 
temperature for 1 h under continuous agitation 
with 2 mM CHAPS. At the end of the incubation, 
the preparation was centrifuged at 100000 x g for 
60 min at 5°C. The clear supernatant fraction con- 
taining approximately 4 mg protein/ml was 
carefully removed and used for the binding 
studies. 
1251-labelled A II receptor binding assays were 
carried out at room temperature for 30 min under 
continuous gentle shaking in 800 ~1 buffer A con- 
taining 1 mM CaCl2 and 1 mM MgClz with 
200-4OOhg of solubilized receptor protein, 1 nM 
12’I-labelled A II, 0.5 mM CHAPS and 125 pug/ml 
l-24 ACTH. The latter product inhibited degrada- 
tion of the tracer without affecting binding kinetics 
[l, 141. Non-specific binding was estimated in 
parallel with tubes containing an additional 
amount of unlabelled A II (1 PM). In order to 
separate free and bound radioactivities, the reac- 
tion mixture was cooled at 0°C and applied to a 
Sephadex G-200 (Pharmacia, Uppsala) column 
(0.9 x 15 cm) equilibrated and eluted (100 pl/min) 
with 20 mM Tris-HCl (pH 7.5). Aliquots (600-/l) 
were collected and 1251 radioactivity was counted 
with a crystal-type scintillation detector giving 
63% efficiency. Bound radioactivity was eluted in 
the initial 6 ml. Elution of proteins was monitored 
by absorbance lecture at 280 nm on a model 25 
Beckman spectrophotometer. This technique was 
long and not ideal for handling great series but we 
found it was the only one providing correct separa- 
tion of bound and free radioactivities in the system 
studied. 
Specific binding to intact isolated glomeruli 
suspended in the same incubation medium was 
studied in parallel in some experiments using 
similar time of incubation and concentration of 
1251-labelled A II. Free and bound radioactivities 
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were separated by filtration through a Millipore 
filter as in [l]. 
Specifically bound radioactivity (total binding 
minus binding in the presence of 1 pM A II) was 
expressed as fmol A II per mg receptor protein, 
both with soluble material and isolated glomeruli. 
3. RESULTS 
1251-labelled A II binding was measured as a 
function of time at varying hormonal concentra- 
tions between 0.1 and 2 nM. Equilibrium was 
reached after 15-20 min. Specific binding 
represented approximately 75% of total binding 
(fig. la). Dissociation after addition of an excess of 
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Fig. 1. (a) Time course of specific binding of ‘251-labelled 
A II to glomerular solubilized receptors at two 
concentrations of ‘251-labelled A II (0.4 and 1.6 nM) in 
the incubation medium. (b) Time-course of total 
(M) and non-specific (M) binding of 1251- 
labelled A II to glomerular solubilized receptors. 
Concentration of 12sI-labelled A II was 1.2 nM. CaC12 
and MgCl2 were omitted in the incubation medium. 
Dissociation of the hormone-receptor complex (A----A) 
was obtained after addition of 1 ,uM unlabelled A II 
after equilibrium had been reached. 
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unlabelfed A II was difficult to obtain in the 
presence of Ca2’ and Mg” in accordance with the 
results that we reported for binding studies with 
untreated glomeruli 1131. When these two cations 
were omitted in the incubation medium, the height 
of the equilibrium plateau was smaller. Dissocia- 
tion in the presence of an excess of unlabelled A II 
was obtained but the rate of dissociation was slow 
and the level of non-specific binding was not 
reached 30 min after addition of the unlabelled 
hormone (figlb). Specific binding was found to 
vary linearly with increasing glomerular protein 
concentration up to 5OOpg per assay tube. The 
equation of the regression line obtained in the 
presence of 1.8 nM ‘251-labeXled A II was: 
y (fmol*mg -’ 12sI-labelled A II) = 
0.007 x Gg glomerular protein) + 
0.073 (r = 0.98, n = 8) 
Dilution of “251-labelled A II (0.6 nM) with in- 
creasing concentrations of unlabelled A II from 
10 pM to 1 FM decreased the percentage of la- 
belled bound hormone. Residual binding at 1 fcM 
was less than 20%. The concentration correspon- 
ding to 5Oa/o f specific binding at zero dose was 
0.76 nM (fig.2). Table 1 illustrates the relative 
potency of various analogs and antagonists for 
competition with ‘Z’I-labelled A II binding at two 
concentrations (1 nM and 1 p&l). Both [Sar’ Alas] 
A II and [Sari Ile*J A II were more potent than 
UP ICI-? to-6 y 
Fig.2, Competitive inhibition of rz51-labelled A II 
binding to glomerular solubilized receptors in the 
presence of increasing concentrations of unlabekd A IL 
Concentration of ‘25f-labelled A II was 0.57 nM. The 
dotted line indicates the concentration corresponding to 
50% inhibition of maximum binding. 
Tabfe 1 
Potency order for displacement of ‘2sf-fabelled A II 
from glomerular solubilized receptors 
Peptide tested Concentrations 
1 nM 2#M 
[Asn’ Val’) A II 61.9 t 1.4 19.8 t 4.3 
[Asp’ lIesI A II 65.1 + 5.2 22.1 + 2.9 
[Des Asp’ Ile’j A II 70.8 + 2.1 25.7 f 1.8 
ISar’ Ala*] A II 33.0 -+ 2.4 20.2 * 2.0 
[Sar’ He81 A ff 42.3 f 3.9 18.7 + 1.6 
Means it SE of 4 individual values are given. Residuaf 
binding expressed as percentage of control binding 
A II itself. [Asp’ Ile’] A II, [Am’ Val’] A II and 
[Des Asp’ Iles] A II had similar inhibitory ac- 
tivities. At 30 min of incubation, less than 20% 
degradation of free Iigand was observed as deter- 
mined by rebinding to fresh glomeruli when l-24 
ACTH was added to the incubation medium. 
The solubilization yield of the ‘2’I-labelled A II 
receptors was calculated by comparison of i2% 
labelled A II binding to isdated glomeruli and to 
the CHAPS-extracted material under the same 
conditions. After 30 min incubation and in the 
presence of 0.6 nM ‘251-labelled A II, isolated 
glomeruii and their solubilized fraction bound 
106.3 f 6.5 and 3.5 f 0.3 fmol ‘251-labelled 
A II/mg protein, respectively. This corresponded 
to a yield of 3.3%. 
4. DISCUSSION 
These findings indicate that the components ex- 
tracted from rat isolated glomerufi with CHAPS 
contain A II receptors. The basic features of 12’f- 
labelled A II binding to the CHAPS-extracted 
material are similar to those observed with un- 
treated glomeruli fl, 14-16]. 30th the particulate 
and the soluble system bind ‘“I-labelled A II 
rapidly at concentrations of hormone between 0.1 
and 2 nM reaching maximum levels in 15-20 min 
and this binding is a linear function of protein con- 
centration. Binding is enhanced in presence of 
Ca2’ and Mg’+. The relative potency of A II 
analogs for competition with “‘1-1abelled A II 
binding is similar to that observed in [16] with par- 
ticulate glomerular receptors. Finally, ‘251-labelled 
245 
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A II is rapidly inactivated by the preparation in the 
absence of l-24 ACTH. Thus, taken together, 
these observations suggest that the soluble lz51- 
labelled A II binding components are the same as 
those formerly identified in untreated isolated 
glomeruli and that their hormone-binding function 
is preserved during the extraction procedure. 
Under the experimental conditions used lz51- 
labelled A II binding was very slowly reversible 
even when Ca2+ and Mg2+ had been omitted in the 
incubation medium. The calculation of association 
and dissociation rate constants was therefore con- 
sidered as incorrect as well as the precise deter- 
mination of a &-value from the Scatchard’s 
transformation of the data obtained in competitive 
inhibition studies. 
Several marked differences between the par- 
ticulate and the extracted receptors are also evi- 
dent. For the extracted receptors, the apparent & 
value estimated from the concentration correspon- 
ding to 50% inhibition of binding in competitive 
inhibition studies was greater than the correspon- 
ding value observed with the particulate receptors 
for the higher affinity group of sites [15]. 
However, other authors using isolated glomeruli 
found a single population of specific receptors 
with an equilibrium dissociation constant between 
0.1 and 1 nM, thus closer to that of the soluble 
receptors [ 14,161. The concentration of specific 
receptors per mg soluble protein was markedly 
lower than that observed with intact glomeruli 
despite the fact that almost all binding activity had 
disappeared from the residual pellet of detergent- 
treated glomeruli. Low recovery of solubilized 
receptors has been already reported in [17] with 
vasopressin receptors in pig kidney plasma mem- 
branes and in [18] in the case of rat testis 
gonadotropin receptor. 
In conclusion, the availability of glomerular 
solubilized receptors for A II in non-membranous 
form can be considered as the first step for their 
further purification and characterization. 
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